Philips joins Optum Healthcare’s network as a preferred provider in the USA
Philips (NYSE: PHG) has established a national partnership with Optum Healthcare in the USA, making its ambulatory and diagnostic solutions available to 3.4 million Optum policyholders across 22 U.S. states. The collaboration focuses on Philips' Mobile Cardiac Telemetry (MCOT) and Extended Holter (ePatch) solutions for enhanced outpatient cardiac monitoring.
The partnership aims to enable earlier detection of cardiac conditions and timely clinical intervention through streamlined patient referral processes. The agreement covers various insurance plans, including commercial, Medicare, Medicare Advantage, and Medicaid. Key benefits include reduced specialist referral delays, enhanced diagnostic insights, seamless care coordination, and increased patient compliance.
Philips (NYSE: PHG) ha stretto una partnership nazionale con Optum Healthcare negli Stati Uniti, offrendo le sue soluzioni ambulatorie e diagnostiche a 3,4 milioni di assicurati Optum in 22 Stati. La collaborazione si concentra sulle soluzioni Mobile Cardiac Telemetry (MCOT) e Extended Holter (ePatch) per un migliore monitoraggio cardiaco ambulatorio.
L’obiettivo della partnership è facilitare una rilevazione precoce delle condizioni cardiache e intervenire tempestivamente tramite percorsi di rinvio dei pazienti più snelli. L’accordo copre diversi piani assicurativi, tra cui Commerciale, Medicare, Medicare Advantage e Medicaid. I principali vantaggi includono una riduzione dei tempi di rinvio agli specialisti, approfondimenti diagnostici migliori, una coordinazione delle cure più fluida e una maggiore adesione dei pazienti.
Philips (NYSE: PHG) ha establecido una asociación nacional con Optum Healthcare en Estados Unidos, poniendo a disposición de 3,4 millones de asegurados de Optum en 22 estados estadounidenses sus soluciones ambulatorias y diagnósticas. La colaboración se centra en las soluciones de Telemetría Cardíaca Móvil (MCOT) y Holter Extendido (ePatch) para un mejor monitoreo cardíaco ambulatorio.
El objetivo de la alianza es facilitar la detección temprana de enfermedades cardíacas y una intervención clínica oportuna mediante procesos de derivación de pacientes más eficientes. El acuerdo abarca diversos planes de seguro, incluidos comerciales, Medicare, Medicare Advantage y Medicaid. Entre los beneficios destacan la reducción de demoras en las derivaciones a especialistas, mejores insights diagnósticos, coordinación de la atención más fluida y una mayor adherencia de los pacientes.
Philips(NYSE: PHG)가 미국에서 Optum Healthcare와 전국적인 파트너십을 체결하여, 22개 주에서 3.4백만 Optum 보험가입자에게 자사의 외래 및 진단 솔루션을 제공합니다. 협력은 이동식 심전도 모니터링(MCOT)과 확장형 홀터( ePatch) 솔루션을 중심으로 외래 심장 모니터링을 강화하는 데 초점을 맞춥니다.
파트너십의 목적은 심장 질환의 조기 발견과 신속한 임상 개입을 가능하게 하는 환자 의뢰 프로세스의 간소화를 통해 이루어집니다. 계약은 상업보험, Medicare, Medicare Advantage, Medicaid를 포함한 다양한 보험 플랜을 포괄합니다. 주요 이점으로는 전문의 의뢰 지연 감소, 진단 인사이트 향상, 원활한 진료 조정, 환자 순응도 증가가 있습니다.
Philips (NYSE: PHG) a établi un partenariat national avec Optum Healthcare aux États‑Unis, rendant ses solutions ambulatoires et diagnostiques accessibles à 3,4 millions d’assurés Optum dans 22 États américains. La collaboration met l’accent sur les solutions de télémétrie cardiaque mobile (MCOT) et Holter étendu (ePatch) pour améliorer le suivi cardiologique en ambulatoire.
L’objectif du partenariat est de permettre une détection précoce des affections cardiaques et une intervention clinique en temps utile via des processus de référence des patients plus efficaces. L’accord couvre divers plans d’assurance, y compris les plans commerciaux, Medicare, Medicare Advantage et Medicaid. Parmi les avantages figurent une réduction des délais de référence vers les spécialistes, des insights diagnostiques améliorés, une meilleure coordination des soins et une plus grande adhésion des patients.
Philips (NYSE: PHG) hat eine nationale Partnerschaft mit Optum Healthcare in den USA etabliert und bietet seine ambulanten und diagnostischen Lösungen 3,4 Millionen Optum-Versicherten in 22 US-Bundesstaaten an. Die Zusammenarbeit konzentriert sich auf Philips’ Mobile Cardiac Telemetry (MCOT) und Extended Holter (ePatch) Lösungen zur verbesserten ambulanten Überwachung des Herz-Kreislauf-Systems.
Ziel der Partnerschaft ist eine frühere Erkennung von Herzerkrankungen und eine zeitnahe klinische Intervention durch optimierte Überweisungsprozesse. Das Abkommen deckt verschiedene Versicherungspläne ab, darunter kommerzielle, Medicare, Medicare Advantage und Medicaid. Zu den wichtigsten Vorteilen zählen verringerte Wartezeiten bei Facharztüberweisungen, vertiefte diagnostische Erkenntnisse, nahtlose Koordination der Versorgung und eine erhöhte Patientencompliance.
Philips (NYSE: PHG) أبرمت شراكة وطنية مع Optum Healthcare في الولايات المتحدة، مع توفير حلولها الخارجية والتشخيصية لـ 3.4 مليون مؤمن Optum عبر 22 ولاية أمريكية. تركز الشراكة على حلول القياس القلبي المتنقل (MCOT) وهولتر الممتد (ePatch) من Philips لتحسين مراقبة القلب خارجيًا.
تهدف الشراكة إلى تمكين الكشف المبكر عن حالات القلب والتدخل السريري في الوقت المناسب من خلال إجراءات إحالة مرضى مبسطة. يغطي الاتفاق خطط تأمين متنوعة بما في ذلك التجاري وMedicare وMedicare Advantage وMedicaid. من المزايا الرئيسية تقليل تأخيرات إحالة المختصين، تحسين الرؤى التشخيصية، تنسيق الرعاية بسلاسة، وزيادة امتثال المرضى.
Philips (NYSE: PHG) 已在美国与 Optum Healthcare 建立全国性伙伴关系，将其门诊与诊断解决方案提供给在 22 个州的 3.4 百万 Optum 保单持有人。该合作聚焦于 Philips 的移动心电监护（MCOT）与扩展型霍特（ePatch）解决方案，以提升门诊心脏监测水平。
该伙伴关系的目标是通过简化患者转诊流程，促进心脏疾病的早期发现和及时临床干预。协议覆盖商业、Medicare、Medicare Advantage 与 Medicaid 等多种保险计划。主要好处包括减少对专家转诊的延迟、诊断洞察力提升、护理协调更无缝，以及患者依从性提高。
- Access to 3.4 million potential patients across 22 U.S. states
- Preferred provider status with major healthcare network Optum
- Coverage across multiple insurance plans including Medicare and Medicaid
- Streamlined referral process potentially leading to increased adoption
- None.
Insights
Philips' partnership with Optum Healthcare grants access to 3.4M patients, boosting revenue potential and strengthening its US cardiac monitoring market position.
Philips has secured a valuable strategic partnership with Optum Healthcare, positioning its Mobile Cardiac Telemetry and Extended Holter monitoring solutions as preferred options for 3.4 million members across 22 states. This agreement significantly expands Philips' patient reach in the competitive US healthcare market.
The partnership holds substantial revenue implications for Philips' Connected Care segment. By becoming an in-network provider, Philips removes a critical barrier to adoption of its cardiac monitoring technologies across multiple insurance types including commercial, Medicare, and Medicaid plans. This improves accessibility and creates a more predictable revenue stream through established reimbursement pathways.
From a competitive standpoint, this partnership strengthens Philips' position against other cardiac monitoring providers like iRhythm Technologies and BioTelemetry. The preferential network status creates a meaningful advantage in physician referral patterns, as in-network options typically receive priority consideration to minimize patient out-of-pocket costs.
For Philips investors, this represents a positive development in the company's US healthcare strategy. The partnership aligns with value-based care trends by emphasizing early detection and prevention through ambulatory monitoring. The focus on streamlined care coordination and improved diagnostic insights addresses healthcare efficiency challenges while potentially reducing costs through earlier intervention - making this arrangement appealing for both Philips and Optum.
September 25, 2025
Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered a national partnership in the USA with Optum Healthcare. The inclusion of Philips’ Mobile Cardiac Telemetry (MCOT) and Philips Extended Holter (ePatch) in the network is designed to enable earlier detection of cardiac conditions and timely clinical intervention. By expanding access to advanced cardiac ambulatory monitoring services for Optum members and streamlining the patient referral process, this collaboration supports proactive care and improved patient outcomes. Philips’ industry-leading solutions are now available to Optum Healthcare’s 3.4 million members in 22 U.S. states.
The access to Philips technology within the network offers several significant benefits for patients, providers and payers:
- Reduced delays in specialist referrals: Streamlined processes help to minimize waiting times for cardiac condition referrals.
- Enhanced diagnostic insights: Improved access to diagnostic data supports more informed clinical decision-making for cardiac issues.
- Seamless care coordination: Ensures smooth transitions throughout the patient journey, from the initial visit to post-discharge.
- Increased patient compliance: User-friendly monitoring and diagnostic devices can encourage better adherence to treatment plans.
These components are crucial in managing chronic conditions effectively.
“Today marks a great step forward in Philips’ ability to reach even more patients and help them receive the care they deserve,” said Julia Strandberg, Chief Business Leader, Connected Care, at Royal Philips. “As a preferred in-network provider, Philips’ cardiac ambulatory monitoring services empower primary care physicians and cardiologists with actionable data that enables them to build stronger collaboration across care teams and can ultimately improve patient outcomes.”
Through this partnership with Optum, Philips is expanding access to its MCOT and ePatch cardiac monitoring solutions across commercial, Medicare, Medicare Advantage or Managed Medicare, and Medicaid plans. These wearable technologies empower clinicians with insights to accelerate clinically smart cardiac care [1], while enabling patients to maintain their daily routines with confidence. This collaboration helps to support providers in delivering efficient care and helps payers advance value-based models.
[1] Data on file.
For further information, please contact:
Allison Johnson
Business Communication Director, Philips
Tel: +1 617-631-7305
E-mail: allison.johnson@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment
FAQ
What is the new partnership between Philips (PHG) and Optum Healthcare?
How many Optum Healthcare members will have access to Philips' cardiac monitoring services?
What cardiac monitoring solutions are included in the Philips-Optum partnership?
What are the main benefits of the Philips-Optum Healthcare partnership?
